Top Manufacturing Companies in Dublin (54)
Atlas is a leading designer and manufacturer of autonomous UAV systems for professional use-cases, that works with a dominant defense, security, and infrastructure institutions in the U.S., the E.U., and Asia. Founded in the EU in 2015 by Aerospace and Robotics professionals with a vision to disrupt the UAV sphere, Atlas utilizes its proprietary and cost-effective technology to provides defense...
Pilot Photonics Ltd offers unique optical comb source subsystems that it develops as a platform technology applicable to many markets including communication, spectroscopy, sensing, and metrology. The company has deep IPR around the generation and application of optical combs which it couples with a powerful capability in photonic integration to produce the world's smallest and most versatile comb sources. Pilot...
Thermo Systems is a full-service control systems integration partner, providing world-class automation solutions within the Energy, Life Sciences, and Mission Critical markets. We excel at managing and delivering turnkey projects to our EPC & AE partners while also specializing in customized direct-to-owner solutions, focusing on industries where we can offer unmatched domain knowledge to deliver the best possible services and...
TEAM Accessories (TA) is an independent aerospace MRO provider with overhaul capabilities on engine accessories, airframe components and airframe safety equipment. TA also have overhaul capabilities on a wide range of industrial gas turbine accessories and components servicing the oil & gas and energy sector. 25 years’ experience supporting a global customer base with bespoke service solutions. Certified Approvals: EASA/...
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...
ICON plc's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global CRO with significant scale and a broad geographic footprint, supported by a major acquisition that strengthened its competitive standing. Operational activity indicators and industry recognition are presented as reinforcing its ability to win and execute large, complex trials.
Profitability: Earnings and operating profit metrics are described as improving in 2024, with increases in GAAP net income, adjusted earnings per share, and adjusted EBITDA. These results suggest the business maintained solid margin performance even as quarterly revenue fluctuated.
Resilient & Sustainable Growth: A large backlog and a book-to-bill above 1.0 in 2024 are cited as providing multi-year revenue visibility and demand coverage. Continued backlog levels into 2025 are described as a stabilizing factor despite a softer near-term revenue trajectory.
Ipsen is a French leading global mid-size biopharmaceutical company headquartered in Paris, France focusing its efforts where unmet medical needs are greatest. Ipsen develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Rare Disease and Neuroscience. We have over 5000 employees worldwide and our medicines are registered in more than 100 countries, with direct commercial presence in...
Ipsen's Top Stability & Growth Strengths
Strong Revenue Growth: Reported results show double-digit growth at constant exchange rates in 2024 and 2025 with an accelerated start in Q1 2026, and guidance indicates continued expansion in 2026. This momentum spans all three therapeutic areas rather than a single product.
Profitability: Disclosures highlight expanding core operating margins above the mid-30s and rising core operating income. Guidance continues to target strong margins alongside growth.
Diversified Revenue Streams: Recent updates indicate contributions from Oncology, Rare Disease, and Neuroscience, with products excluding Somatuline growing strongly and rare disease accelerating. Strategic acquisitions and partnerships have broadened the base beyond any single legacy brand.
Analog Devices, Inc. (NASDAQ: ADI) operates at the center of the modern digital economy, converting real-world phenomena into actionable insight with its comprehensive suite of analog and mixed signal, power management, radio frequency (RF), and digital and sensor technologies. ADI serves 125,000 customers worldwide with more than 75,000 products in the industrial, communications, automotive, and consumer markets. ADI is headquartered...
Analog Devices's Top Stability & Growth Strengths
Strong Market Position & Advantage: Analog Devices is positioned as a top-tier analog and mixed-signal semiconductor provider with leadership in key niches like data converters and a “premium position” in complex, high-performance analog. Its design-in “stickiness” in long-lifecycle systems is described as supporting predictable, long-term revenue.
Strong Revenue Growth: Recent results show a rebound and acceleration, including fiscal 2025 revenue growth versus 2024 and strong year-over-year growth in the most recent quarter with higher near-term revenue guidance. Forward-looking expectations also indicate continued expansion over the next several years.
Healthy Cash Flow: Cash generation is described as robust, with strong operating and free cash flow enabling sizable shareholder returns through dividends and repurchases. Ongoing dividend increases are presented as consistent with confidence in durable cash generation.
Plasma Bound provides a step-change technology, termed Controlled Polymer Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, by enabling reliable adhesive joining which is stronger than the composite structures themselves. The technology will satisfy the...
At EMA Aesthetics we believe that life is an art and everything we do embraces that art. Our approach is avant-garde designed to challenge the status quo. We focus on combination therapy that enhances aesthetic procedures. Results over sentiment. At EMA Aesthetics we regard customers as our partners. Working together, we provide best-in-class aesthetic solutions that yield beautiful returns and...
Integra LifeSciences, a world leader in medical technology with headquarters in Princeton, New Jersey, was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has expanded its base regenerative technology product portfolio to include surgical instruments, neurosurgical products and advanced wound care products, through global acquisitions and development...
Perrigo Company plc, is a global consumer self-care company. Our vision is: To make lives better by bringing "Quality, Affordable Self-Care Products" that consumers trust everywhere they are sold. Founded in 1887 as a packager of home remedies, Perrigo has transformed to a self-company which enables the empowered consumer to treat conditions that can be self-managed. Perrigo is the world's largest...
At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal...
Uniphar is a diversified healthcare services organisation with activities in Ireland, UK, Europe, the USA and APAC
WGNSTAR, formerly Westerwood Global and NSTAR Global Services, is a trusted partner to many of the world’s leading semiconductor manufacturers, providing innovative and cost-efficient managed workforce services and asset lifecycle management solutions. We partner with our clients to build a custom approach which ensures we deliver a workforce solutions plan that is tailored to their specific operations and ultimate business...
For over 240 years, Takeda’s propensity to evolve has driven the next generation of innovation, and as a future-focused organization, we’re continuing to drive forward with endurance in our steadfast pursuit to achieve the best outcomes for our patients in a rapidly changing world. We have been preparing for this period of value creation by investing in data, digital and...
Takeda's Top Stability & Growth Strengths
Strong Market Position & Advantage: Takeda is consistently placed among the global top 15–20 by revenue and is a clear category leader in GI/IBD, plasma-derived therapies, and dengue vaccines with broad international authorizations and WHO support. Subcutaneous ENTYVIO and new oncology approvals like FRUZAQLA broaden real‑world use and extend reach.
Profitability: Reported FY2025 operating profit rose 19.3% year over year and EPS nearly doubled despite a slight revenue decline, supported by lower amortization and restructuring expense. Core profitability remained broadly stable as Growth & Launch Products expanded their share.
Future-Ready Strategy: Management is investing through FY2026 to convert a late‑stage pipeline (e.g., oveporexton, rusfertide, zasocitinib) into multiple launches, with Growth & Launch Products prioritized as near‑term engines. A multi‑year transformation and efficiency program targeting significant savings by FY2028 is intended to fund launches and strengthen competitiveness.
Eco Urban Scooters and ZEUS Scooters is an Irish owned and operated electric scooter sharing provider. We strive to reduce congestion on city streets and bring sensible urban commuting to you
Rejuvant is a science-backed, purpose-driven longevity wellness brand elevating functionally innovative ingredients into a proprietary patent pending compound to enhance healthspan. Its core mission is to rise up against and reverse the aging process, using science backed data, engaging in consumer education and manufacturing Rejuvant through a slow release mechanism with the highest standards of purity, potency and transparency. Rejuvant...
Phoenix Contact is an independent, global market leader with headquarters in Blomberg, Germany. More than 20,000 enthusiastic people around the world develop, produce, and sell our creative solutions in connection technology, electronics, and automation. The "Phoenix terminals" and "Phoenix connectors" are known worldwide. We see our work as a contribution to designing a smart world. A global network in more than...
IPS-Integrated Project Services, LLC, a Berkshire Hathaway company, is a global leader in developing innovative solutions for the consulting, architecture, engineering, project controls, procurement, construction management, and CQV of technically complex facilities worldwide. With technical expertise spanning R&D to pilot-scale to large-scale production, our team specializes in the technology, trends, and regulatory environment to successfully deliver capital projects and improve...
